Search
for
Sort by
Research 361–390 of 1000+
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- What causes hidradenitis suppurativa ?—15 years after
- Cell Types Promoting Goosebumps Form a Niche to Regulate Hair Follicle Stem Cells
- A new path in defining light parameters for hair growth: Discovery and modulation of photoreceptors in human hair follicle
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Trans‐species hair growth induction by human hair follicle dermal papillae
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Interventions for nail psoriasis
- Induced Pluripotent Stem Cells from Human Hair Follicle Mesenchymal Stem Cells
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- Female Pattern Hair Loss
- How to diagnose a lipodystrophy syndrome
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
- The Polycystic Ovary Syndrome Evolutionary Paradox: a Genome-Wide Association Studies–Based, in silico, Evolutionary Explanation
- Hair: What is New in Diagnosis and Management?
- 5α-Reduced glucocorticoids: a story of natural selection
- SCALP HAIR CHARACTERISTICS IN THE NEWBORN INFANT
- Regulation of masculinization: androgen signalling for external genitalia development
- Androgen receptor gene polymorphism and polycystic ovary syndrome
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- To grow or not to grow: Hair morphogenesis and human genetic hair disorders
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Mood disorders and quality of life in polycystic ovary syndrome
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Anabolic-androgenic steroids and cardiovascular risk
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Redefining hormone resistance in prostate cancer
- Assessment of a Bidirectional Association Between Major Depressive Disorder and Alopecia Areata